The expression of CSC gene signatures (CD44 and ALDH1A1) in human breast cancer cells with high autocrine TGFβ signaling can be downregulated by a TGFβ inhibitor (TGFβi) that targets TGFβ receptor‐I (TGFR‐I).16 This evidence concerns the gene TGFB1 and breast cancer.